This activity is provided by Haymarket Medical Education (HME) for physician credit.

This activity is co-provided by Medical Education Resources (MER) for nursing contact hours.

Kristyn Gentry, MSPAS, PA-C
Richmond, Va.

Continue Reading

William A. Childers, Jr., EdD, MS, PA-C
West Liberty University Physician Assistant Program
W. Va.

Release Date: March 13, 2015
Expiration Date: March 12, 2016
Estimated time to complete the educational activity: 30 minutes

Statement of Need: Takotsubo cardiomyopathy is a possible cause of chest pain evaluated daily in primary care settings and hospitals. Practitioners must be aware of the condition to facilitate expedited care, evaluation, and management of these patients. Clinical suspicion for takotsubo cardiomyopathy in primary care practices and hospitals will minimize complications and optimize outcomes for these patients.

Target Audience: This activity has been designed to meet the educational needs of primary care health care professionals who will treat patients with acute chest pain who may have takotsubo cardiomyopathy.

Learning Objectives: After completing the activity, the participant should be better able to:

  • Describe the differential diagnosis for acute chest pain, including takotsubo cardiomyopathy
  • Explain appropriate evaluation for a patient with high clinical suspicion of the condition
  • Define important laboratory and imaging findings that confirm the diagnosis of takotsubo cardiomyopathy
  • Apply supportive treatment approaches for management of patients with takotsubo cardiomyopathy and associated complications

Accreditation Statements

Physician Credit: HME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical ­education for physicians.

Credit Designation: HME designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit<sup?tm TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. </sup?tm

Nursing Credit: MER is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation: This CE activity provides 0.5 contact hour ofcontinuing nursing education.MER is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 0.5 contact hour.

This activity qualifies for 0.20 pharmacotherapy credit.

American Academy of Physician Assistants (AAPA)

The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a ­maximum of 0.5 hour of Category I credit for completing this program.

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest in an effort to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

Furthermore, HME seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. HME is ­committed to providing its learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

The faculty reported the following financial relationships withcommercial interests whose products or services may be mentioned inthis CME/CE activity:

Faculty Disclosures

Name of Faculty Financial Relationship
Kristyn Gentry, MSPAS, PA-C No relevant financial relationships
William A. Childers, Jr., EdD, MS, PA-C No relevant financial relationships

Staff, Planners, Managers, and Reviewer Disclosures

The staff, planners, managers, and reviewers for this program reported the following ­financial relationships with commercial interests whose products or services may be related to the content of this CME activity:

HME staff, planners, managers, and content reviewers have no relevant financial relationships to disclose.

MER planners and managers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HME and MER do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation: There are no fees for participating in and receiving CME/CE credit for this activity. During the period of March 13, 2015, through March 12, 2016, participants must:

  1. Read the learning objectives and faculty disclosures;
  2. Study the educational activity;
  3. Submit the post-test online (clinicians may register at;
  4. Complete the evaluation form online

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

Disclaimer: The content and views presented in this educational activityare those of the authors and do not necessarily reflect those of HME orMER. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serveas a guideline for patient management.

HOW TO TAKE THE POST-TEST: Click here after reading the article to take the post-test on